Join
Live feed
·
PRReleasevia Quantisnow
Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ByQuantisnow·Wall Street's wire, on your screen.
RARE· Ultragenyx Pharmaceutical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RARE (Ultragenyx Pharmaceutical Inc.) and more on Quantisnow.